Brief: INmune Bio Inc. Patent Claims Covering Inb16 Cell Line And Inkmune Therapeutic Composition Given Favorable Patentability Opinion By International Search Authority
31/10/2023 12:05
Oct 31 (Reuters) - INmune Bio Inc INMB.O :
* INMUNE BIO INC. PATENT CLAIMS COVERING INB16 CELL LINE AND
INKMUNE™ THERAPEUTIC COMPOSITION GIVEN FAVORABLE PATENTABILITY
OPINION BY INTERNATIONAL SEARCH AUTHORITY
Source text for Eikon: ID:nGNX4Q1JsZ
Further company coverage: INMB.O
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview